Foamix Pharmaceuticals Ltd. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 56 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-03-09: Reporting owner STERN STANLEY; Form 4; Security Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-03-09: Reporting owner STERN STANLEY; Form 4; Security Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-03-09: Reporting owner STERN STANLEY; Form 4; Security Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-03-09: Reporting owner STERN STANLEY; Form 4; Security Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-03-09 | STERN STANLEY Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,000 0 owned after | $5.88 exercise price | 2020-03-18 | |
| 2020-03-09 | STERN STANLEY Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,562 0 owned after | $4.76 exercise price | 2020-03-18 | |
| 2020-03-09 | STERN STANLEY Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,947 0 owned after | $5.06 exercise price | 2020-03-18 | |
| 2020-03-09 | STERN STANLEY Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,719 0 owned after | $3.53 exercise price | 2020-03-18 | |
| 2020-03-09 | Wiley Matthew T. Officer (Chief Commercial Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −100,000 0 owned after | $4.06 exercise price | 2020-03-11 | |
| 2020-03-09 | Wiley Matthew T. Officer (Chief Commercial Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −96,365 0 owned after | $4.03 exercise price | 2020-03-11 | |
| 2020-03-09 | Stuart Iain Officer (Chief Scientific Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,000 0 owned after | $8.54 exercise price | 2020-03-11 | |
| 2020-03-09 | Stuart Iain Officer (Chief Scientific Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −13,000 0 owned after | $5.39 exercise price | 2020-03-11 | |
| 2020-03-09 | Stuart Iain Officer (Chief Scientific Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $6.35 exercise price | 2020-03-11 | |
| 2020-03-09 | Stuart Iain Officer (Chief Scientific Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −75,997 0 owned after | $3.77 exercise price | 2020-03-11 | |
| 2020-03-09 | Stuart Iain Officer (Chief Scientific Officer) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −96,365 0 owned after | $4.03 exercise price | 2020-03-11 | |
| 2020-03-09 | Schwartz Aharon Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $11.87 exercise price | 2020-03-11 | |
| 2020-03-09 | Schwartz Aharon Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,435 0 owned after | $4.69 exercise price | 2020-03-11 | |
| 2020-03-09 | Schwartz Aharon Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,883 0 owned after | $5.02 exercise price | 2020-03-11 | |
| 2020-03-09 | Schwartz Aharon Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,412 0 owned after | $2.66 exercise price | 2020-03-11 | |
| 2020-03-09 | Schwartz Aharon Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,156 0 owned after | $3.53 exercise price | 2020-03-11 | |
| 2020-03-09 | KAZANCHYAN ANNA Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,000 0 owned after | $5.88 exercise price | 2020-03-11 | |
| 2020-03-09 | KAZANCHYAN ANNA Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,000 0 owned after | $10.80 exercise price | 2020-03-11 | |
| 2020-03-09 | Hirsch Stanley Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,000 0 owned after | $5.88 exercise price | 2020-03-11 | |
| 2020-03-09 | Hirsch Stanley Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,153 0 owned after | $4.69 exercise price | 2020-03-11 | |
| 2020-03-09 | Hirsch Stanley Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,766 0 owned after | $5.02 exercise price | 2020-03-11 | |
| 2020-03-09 | Harsch Mutya Officer (CLO and General Counsel) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $6.35 exercise price | 2020-03-11 | |
| 2020-03-09 | Harsch Mutya Officer (CLO and General Counsel) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −70,297 0 owned after | $3.77 exercise price | 2020-03-11 | |
| 2020-03-09 | Harsch Mutya Officer (CLO and General Counsel) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −96,365 0 owned after | $4.03 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,469 0 owned after | $1.92 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,125 0 owned after | $5.46 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,000 0 owned after | $6.77 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −202,004 0 owned after | $7.13 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $6.34 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,389 0 owned after | $10.31 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −196,205 0 owned after | $5.22 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,093 0 owned after | $6.40 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −94,996 0 owned after | $3.81 exercise price | 2020-03-11 | |
| 2020-03-09 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −96,365 0 owned after | $4.03 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,750 0 owned after | $7.98 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −236,810 0 owned after | $7.14 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $6.04 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −71,369 0 owned after | $10.22 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −327,720 0 owned after | $5.76 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −70,187 0 owned after | $5.06 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −170,993 0 owned after | $3.77 exercise price | 2020-03-11 | |
| 2020-03-09 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −240,912 0 owned after | $4.03 exercise price | 2020-03-11 | |
| 2020-03-09 | Bright Rex Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,000 0 owned after | $5.88 exercise price | 2020-03-11 | |
| 2020-03-09 | Bright Rex Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,562 0 owned after | $4.76 exercise price | 2020-03-11 | |
| 2020-03-09 | Bright Rex Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,947 0 owned after | $5.06 exercise price | 2020-03-11 | |
| 2020-03-09 | Bright Rex Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,412 0 owned after | $2.66 exercise price | 2020-03-11 | |
| 2020-03-09 | Bright Rex Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,156 0 owned after | $3.53 exercise price | 2020-03-11 | |
| 2020-03-09 | BARBARI SHARON SURREY Director | 4 | Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,412 0 owned after | $2.66 exercise price | 2020-03-11 | |
| 2020-02-27 | STERN STANLEY Director | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,719 12,719 owned after | $3.53 exercise price | 2020-03-03 | |
| 2020-02-27 | Schwartz Aharon Director | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,156 38,156 owned after | $3.53 exercise price | 2020-03-03 | |
| 2020-02-27 | Bright Rex Director | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,156 38,156 owned after | $3.53 exercise price | 2020-03-03 | |
| 2020-02-24 | Wiley Matthew T. Officer (Chief Commercial Officer) | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,365 96,365 owned after | $4.03 exercise price | 2020-02-24 | |
| 2020-02-24 | Stuart Iain Officer (Chief Scientific Officer) | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,365 96,365 owned after | $4.03 exercise price | 2020-02-24 | |
| 2020-02-24 | Harsch Mutya Officer (CLO and General Counsel) | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,365 96,365 owned after | $4.03 exercise price | 2020-02-24 | |
| 2020-02-24 | Hadar Ilan Officer (CFO & Country Manager) | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +96,365 96,365 owned after | $4.03 exercise price | 2020-02-24 | |
| 2020-02-24 | Domzalski David Director, Officer (CEO) | 4 | Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +240,912 240,912 owned after | $4.03 exercise price | 2020-02-24 |